IDXG · Interpace Biosciences, Inc.
Market Cap
$42.19M
Shares
5.54M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-27 | — | |
| 8-K/A | 2026-08-26 | 2026-08-20 | |
| 8-K | 2026-08-21 | 2026-08-20 | |
| 8-K | 2026-08-12 | 2026-08-10 | |
| 10-Q | 2026-08-10 | 2026-06-30 | |
| DEF 14A | 2026-07-07 | — | |
| 8-K | 2026-05-14 | 2026-05-12 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-04-01 | 2026-03-30 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2025-12-03 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-08-08 | 2025-08-07 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-01 | 2025-04-25 | |
| 10-K/A | 2025-04-28 | 2024-12-31 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-06 | 2025-02-28 | |
| 8-K | 2025-01-27 | — | |
| 8-K | 2025-01-21 | 2025-01-14 | |
| 8-K | 2025-01-10 | 2025-01-09 | |
| 8-K | 2024-11-13 | 2024-11-12 | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-06 | 2024-11-04 | |
| 8-K | 2024-10-15 | 2024-10-10 | |
| DEF 14A | 2024-09-20 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-02 | 2024-08-01 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 10-K/A | 2024-04-26 | 2023-12-31 | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-03-13 | 2024-03-07 | |
| 8-K | 2023-12-12 | 2023-12-07 | |
| 8-K | 2023-11-16 | 2023-11-14 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — | |
| 8-K | 2023-10-27 | 2023-10-24 | |
| DEF 14A | 2023-09-22 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-09 | — | |
| 8-K | 2023-08-02 | 2023-07-31 | |
| 10-Q | 2023-05-12 | 2023-03-31 | |
| 8-K | 2023-05-12 | — | |
| 10-K/A | 2023-04-28 | 2022-12-31 |
Showing 1–50 of 126 filings